| Filed On | Filing |
|---|---|
| 30 Sep 2022 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 25 Apr 2019 |
8-K/A: Financial Statements and Exhibits
The following sets forth the unaudited pro forma condensed combined financial statements (the “Pro Forma Financial Statements”) of BioTime after giving effect to the Merger with Asterias (the “Merger”), which was completed on March 8, 20... |
| 14 Aug 2017 |
8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
Michael D. West, Ph.D., Aditya Mohanty, and Judith Segall certify that: |
| 16 Jul 2010 |
8-K/A: Completion of Acquisition or Disposition of Assets
Financial Statements for Years Ended March 31, 2009 and 2010 |
| 24 Oct 2007 |
8-K/A: Departure/Election of Directors or Officers; Compensation
The following sentence amends the corresponding information included in BioTime’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 12, 2007. |
Loading...